Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II randomized double-blind trial of adjuvanted quadrivalent split influenza vaccine (ZFA02)
CTR20250312Phase 2Active
- Sponsor
- Anhui Zhifei Longcom Biopharmaceutical
- Start
- May 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ZFA02 quadrivalent influenza vaccine in influenza, sponsored by Anhui Zhifei Longcom Biopharmaceutical. Started May 2025; status: active.
02
Drugs
ZFA02 quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20250312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250312.